Related Experiment Video
Updated: Jul 14, 2026
06:21
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Cellular mechanisms of brain hypoglycemia
N K Isaev1, E V Stel'mashuk, D B Zorov
1Belozersky Institute of Physico-Nhemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia. isaev@genebee.msu.su
Biochemistry. Biokhimiia
|June 19, 2007
Summary
Low glucose levels trigger damaging intracellular processes in nerve tissue. Neuronal mitochondria calcium overload increases reactive oxygen species (ROS) production, leading to cell damage during hypoglycemia.
Area of Science:
- Neuroscience
- Cellular Biology
- Biochemistry
Background:
- Hypoglycemia, or low blood glucose, poses a significant threat to neuronal function and survival.
- Understanding the specific intracellular mechanisms underlying neuronal damage during hypoglycemia is crucial for developing therapeutic strategies.
Purpose of the Study:
- To elucidate the intracellular processes in nerve tissue induced by low glucose levels.
- To investigate the roles of glutamate and adenosine receptors, mitochondria, reactive oxygen species (ROS), and calcium ions in hypoglycemia-induced neuronal damage.
Main Methods:
- This study reviews existing data on intracellular events during low glucose conditions in nerve tissue.
- It focuses on the interplay between key cellular components implicated in neuronal injury.
Main Results:
- Low glucose levels activate complex intracellular pathways in neurons.
- The study highlights the involvement of glutamate and adenosine receptors, mitochondria, ROS, and calcium ions in this process.
- A key finding suggests that calcium overload in neuronal mitochondria is a critical event.
Conclusions:
- Hypoglycemia-induced calcium overload in neuronal mitochondria leads to increased ROS production.
- This elevated ROS production by mitochondria is a primary driver of neuronal damage during low glucose conditions.
Related Concept Videos
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:02Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.